EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Real-world experience of Teduglutide use in adults with short bowel syndrome: A seven-year international multicenter survey

Francisca Joly, Denise Jezerski, Ulrich-Frank Pape, Adriana Crivelli, Elisabeth Hütterer, Charlotte Bergoin, Anna S Sasdelli, Umberto Aimasso, Stéphane M Schneider, Florian Poullenot, David Seguy, Brooke Chapman und 38 weitere

Clinical Nutrition · 2025

DOI: 10.1016/j.clnu.2025.01.026 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Nutrition, 2025. Verfasst von Francisca Joly und 49 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Intestinal Failure, Department of Gastroenterology and Nutritional Support, Hôpital Beaujon, Clichy, France. Hauptthemen laut MEDLINE: Short Bowel Syndrome, Peptides, Gastrointestinal Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIM: Teduglutide is a glucagon-like peptide-2 analogue used to promote intestinal rehabilitation and decrease the dependence from intravenous supplementation (IVS) in patients with short bowel syndrome and intestinal failure (SBS-IF). The aim of this study was to gain a better understanding of international real-world Teduglutide use since its launch. METHODS: Data from an international multicenter database for chronic IF were analysed. All the adult patients with SBS-IF included by centers that treated at least one patient with Teduglutide during the study period (2015-2022) were investigated. The baseline characteristics and the outcome of patients treated with Teduglutide (n.269) were compared to those of patients not receiving the drug (Controls, n.3081). The center experience was categorized based on the number of patients treated with Teduglutide:

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Short Bowel SyndromePeptidesGastrointestinal AgentsHumansMaleFemaleMiddle AgedAdultAgedTreatment OutcomeIntestinal Failure

Stichwörter der Autor:innen

Glucagon-like peptide-2Home parenteral nutritionIntestinal failureIntravenous supplementationShort bowel syndromeTeduglutide

Substanzen

teduglutidePeptidesGastrointestinal Agents

Autor:innen und Institutionen

  • Centre for Intestinal Failure, Department of Gastroenterology and Nutritional Support, Hôpital Beaujon, Clichy, France.
  • Home Nutrition Support, Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Charité Universitaetsmedizin Berlin, Germany; Department of Internal Medicine and Gastroenterology, Asklepios Clinic St. Georg, Asklepios Medical School, Hamburg, Germany.
  • Unidad de Soporte Nutricional, Rehabilitación y Trasplante de Intestino, Hospital Universitario Fundacion Favaloro, Buenos Aires, Argentina.
  • Department of Medicine I, Division of Oncology, Medical University of Vienna, Austria.
  • Service Hépato-gastro-entérologie et Assistance Nutritionnelle, CHU Lyon Sud, Oullins-Pierre Bénite, Lyon, France.

Zitieren

APA

Joly, F., Jezerski, D., Pape, U. F., Crivelli, A., Hütterer, E., Bergoin, C., Sasdelli, A. S., Aimasso, U., Schneider, S. M., Poullenot, F., Seguy, D., Chapman, B., Sobocki, J., Regano, N., Lamprecht, G., Layec, S., Santarpia, L., Kozjek, N. R., Gallitelli, L., …, & Pironi, L. (2025). Real-world experience of Teduglutide use in adults with short bowel syndrome: A seven-year international multicenter survey. Clinical Nutrition. https://doi.org/10.1016/j.clnu.2025.01.026

Vancouver

Joly F, Jezerski D, Pape UF, Crivelli A, Hütterer E, Bergoin C, et al. Real-world experience of Teduglutide use in adults with short bowel syndrome: A seven-year international multicenter survey. Clinical Nutrition. 2025. doi:10.1016/j.clnu.2025.01.026

BibTeX
@article{Joly2025,
  author = {Joly, Francisca and Jezerski, Denise and Pape, Ulrich-Frank and Crivelli, Adriana and Hütterer, Elisabeth and Bergoin, Charlotte and Sasdelli, Anna S and Aimasso, Umberto and Schneider, Stéphane M and Poullenot, Florian and Seguy, David and Chapman, Brooke and Sobocki, Jacek and Regano, Nunzia and Lamprecht, Georg and Layec, Sabrina and Santarpia, Lidia and Kozjek, Nada Rotovnik and Gallitelli, Livia and Lopez-Urdiales, Rafael and Fehr, Rebecca and Itzhaki, Moran Hellerman and Maíz-Jiménez, María and Carey, Sharon and Taus, Marina and Francini-Pesenti, Francesco and Rasmussen, Henrik H and Vanuytsel, Tim and Cuerda, Cristina and Thibault, Ronan and Chen, Mona and Osland, Emma and Krznaric, Zeljko and Martins da Rocha, Mariana Hollanda and Martinuzzi, Andrés L N and Bezmarević, Mihailo and Diez, Marta Bueno and Livovsky, Dan M and Aguayo, Pilar Serrano and Orlandoni, Paolo and Pelaez, Rosa Burgos and Campos Martín, Cristina and Ellegard, Lars and Lezo, Antonella and Boluda, Esther Ramos and Gandullia, Paolo and Blüthner, Elizabeth and Zarpellon, Martina and Lal, Simon and Pironi, Loris},
  title = {Real-world experience of Teduglutide use in adults with short bowel syndrome: A seven-year international multicenter survey},
  journal = {Clinical Nutrition},
  year = {2025},
  doi = {10.1016/j.clnu.2025.01.026}
}
Kostenlos starten →